Schulz V
Clin Pharmacokinet. 1984 May-Jun;9(3):239-51. doi: 10.2165/00003088-198409030-00005.
Sodium nitroprusside decomposes within a few minutes after intravenous infusion to form metabolites which are pharmacologically inactive but toxicologically important. Free cyanide, which represents 44% w/w of the sodium nitroprusside molar mass, is formed and must be detoxified in the body into thiocyanate using thisulphate as substrate. Nitroprusside penetrates cell membranes slowly. At therapeutic dose levels its distribution is probably mainly extracellular. Contact with the sulfhydryl groups in the cell walls, however, immediately initiates breakdown of the molecule. Sodium nitroprusside taken orally is not absorbed from the gastrointestinal tract to any appreciable extent. Cyanides in the body form prussic acid, which can rapidly penetrate mucous and cell membranes. In the blood, about 99% of the prussic acid binds to the methaemoglobin of erythrocytes. At normal physiological levels, however, the total body methaemoglobin of an adult human can only bind about 10mg of prussic acid; this is a small fraction of the amounts usually infused therapeutically as sodium nitroprusside. The endogenous detoxification of prussic acid exhibits zero-order kinetics. The limiting factor is a sulphur donor, principally thiosulphate, which is available in the body in only limited amounts. The rate of spontaneous detoxification of prussic acid in humans is only about 1 microgram/kg/min, corresponding to a sodium nitroprusside infusion of about 2 microgram/kg/min. This dose limit set by the prussic acid toxicity of sodium nitroprusside can, however, be increased considerably by simultaneous infusion of thiosulphate. A lack of thiosulphate can be detected early by a rise of the prussic acid concentration in the erythrocytes. Thiosulphate taken orally is not absorbed by the body. After intravenous infusion, its serum half-life is about 15 minutes. Most of the thiosulphate is oxidised to sulphate or is incorporated into endogenous sulphur compounds; a small proportion is excreted through the kidneys. Thiocyanate taken orally is completely absorbed by the body. In healthy persons its volume of distribution is approximately 0.25 L/kg and the serum half-life about 3 days; elimination is mainly renal. Thiocyanate toxicity does not represent a serious therapeutic problem with intravenous infusion of sodium nitroprusside.
硝普钠静脉输注后几分钟内就会分解,形成药理上无活性但毒理学上很重要的代谢产物。会生成游离氰化物,其占硝普钠摩尔质量的44%(重量/重量),必须在体内以硫代硫酸盐为底物将其解毒为硫氰酸盐。硝普钠缓慢穿透细胞膜。在治疗剂量水平时,其分布可能主要在细胞外。然而,与细胞壁中的巯基接触会立即引发分子分解。口服硝普钠在胃肠道内基本不被吸收。体内的氰化物会形成氢氰酸,它能迅速穿透黏液和细胞膜。在血液中,约99%的氢氰酸与红细胞的高铁血红蛋白结合。然而,在正常生理水平下,成年人体内的总高铁血红蛋白只能结合约10毫克氢氰酸;这只是治疗中通常作为硝普钠输注量的一小部分。氢氰酸的内源性解毒呈现零级动力学。限制因素是硫供体,主要是硫代硫酸盐,其在体内的量有限。人体中氢氰酸的自发解毒速率仅约为1微克/千克/分钟,相当于硝普钠输注量约为2微克/千克/分钟。然而,通过同时输注硫代硫酸盐,硝普钠因氢氰酸中毒设定的这个剂量限制可以大幅提高。红细胞中氢氰酸浓度升高可早期检测到硫代硫酸盐缺乏。口服硫代硫酸盐不被人体吸收。静脉输注后,其血清半衰期约为15分钟。大部分硫代硫酸盐被氧化为硫酸盐或并入内源性硫化合物;一小部分通过肾脏排泄。口服硫氰酸盐可被人体完全吸收。在健康人中,其分布容积约为0.25升/千克,血清半衰期约为3天;主要通过肾脏排泄。静脉输注硝普钠时,硫氰酸盐中毒并不构成严重的治疗问题。